By Jacqueline Howard, CNN(CNN) — A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-...

Roughly 2 million baked good products, some of which were sold at Dunkin’ Donuts locations nationwide, have been recalled over concerns of l...

EMBLAVEOTM is the first and only monobactam/β-lactamase inhibitor combination antibiotic therapy approved by the U.S. FDA to treat complicat...

A pharma industry group is urging the U.S. Food and Drug Administration (FDA) to block what it calls a “dangerous” Super Bowl ad from the di...

Changes or updates to hardware or software can result in loss of alerts. Medscape Medical News

Class 1 recalls are given in situations where there could be serious health consequences.

A recent recall involving bags of broccoli sold at Walmart potentially contaminated with listeria has now been categorized by the Federal Dr...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug your doctor prescr...

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as the originator...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Three products from Cal Yee Farm’s recall last month are now a ‘Class 1’ level

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depressio...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with or without aur...

The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside the brain, block...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.